Kymera Therapeutics Inc. Common Stock vs Sotera Health Company Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.06B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Sotera Health Company Common Stock is more actively traded (2,279,715 versus 1,028,790). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| KYMR | SHC | |
|---|---|---|
Market Cap | $8.88B | $5.06B |
Volume | 1,028,790 | 2,279,715 |
Sector | Health | Health |
52-Week High | $127.31 | $19.57 |
52-Week Low | $55.80 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.27B | $6.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →